Carulli Michael 4
4 · PMV Pharmaceuticals, Inc. · Filed Sep 12, 2024
Insider Transaction Report
Form 4
Carulli Michael
Chief Financial Officer
Transactions
- Sale
Common Stock
2024-09-11$1.50/sh−2,891$4,347→ 88,395 total
Footnotes (1)
- [F1]These reported shares were sold to cover the reporting person's tax obligation in connection with the vesting of restricted stock units, or RSUs.